Mitsubishi UFJ Morgan Stanley Securities Co., Ltd.
Broker-DealerPosition in MRK — Merck & Co., Inc.
CIK 1545545
TOKYO, M0
Position in MRK
as of Jun 30, 2026
· filed Jul 15, 2026
Position Value
$72,602
-$117,095 QoQ
Shares Held
565
-64.2% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.22%
of 13F equity value
Holder Rank
#3,620
of 3,769 holders
Holding Since
Dec 2021
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Mitsubishi UFJ Morgan Stanley Securities Co., Ltd. holds $563,108 across 8 Drug Manufacturers - General names. MRK ranks #3 (12.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
310 | $78,008 | |
| 2 | LLY |
ELI LILLY & Co
|
65 | $77,962 | |
| 3 | MRK |
Merck & Co., Inc.
This page
|
565 | $72,602 | |
| 4 | JNJ |
Johnson & Johnson
|
284 | $72,127 | |
| 5 | AMGN |
Amgen Inc
|
194 | $70,251 | |
| 6 | AZN |
Astrazeneca PLC
|
353 | $66,935 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
1,123 | $64,707 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
479 | $60,516 |
All Filings in MRK
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $72,602 | 565 | Shares | Defined | 2026-07-15 | |
| 2026-03-31 | $189,697 | 1,577 | Shares | Defined | 2026-04-30 | |
| 2022-12-31 | $137,578 | 1,240 | Shares | Defined | 2023-01-24 | |
| 2022-09-30 | $172,240 | 2,000 | Shares | Defined | 2022-11-08 | |
| 2022-06-30 | $179,604 | 1,970 | Shares | Defined | 2022-08-02 | |
| 2022-03-31 | $28,717 | 350 | Shares | Defined | 2022-05-04 | |
| 2021-12-31 | $52,881 | 690 | Shares | Defined | 2022-02-10 | |
| No filing history on record for this holder in this stock. | ||||||